Review Papers - KON Tomoya
-
Parkinson
Tomiyama M, Kon T
S 33 ( 6 ) 642 - 645 2016.11
-
HTLV-1
Ebina T, Kon T
Rinshoshinkeigaku 56 ( 11 ) 807 - 807 2016.11
-
MSA
KON T
MDSJ 10 92 - 92 2016.10
-
PSP
Nunomura J, Kon T
MDSJ 10 93 - 93 2016.10
-
QOL
Ueno T, Kon T
MDSJ 10 77 - 77 2016.10
-
Dpn
Suzuki C, Kon T
R 44 ( 5 ) 429 - 429 2016.10
-
D
Tomiyama M, Kon T
S 33 ( 5 ) S206 - S206 2016.10
-
α
Kon T
Aomori Kenritsu Tyuuoubyouin Ishi 61 ( 3 ) 125 - 126 2016.9
-
GBS
Suzuki C, Kon T
S 21 ( 1 ) 160 - 160 2016.9
-
HTLV-1-associated myelopathy
Ueno T, Kon T
NEUROINFECTION 21 ( 2 ) 204 - 204 2016.9
-
4
Takabayashi A, Kon T
Aomori Kenritsu Tyuuoubyouin Ishi 61 ( 3 ) 109 - 113 2016.9
-
NMO spectrum disorder
Takabayashi A, Kon T
Rinshoshinkeigaku 56 ( 8 ) 589 - 589 2016.8
-
SRP
Nishijima H, Kon T
Rinshoshinkeigaku 56 ( 8 ) 589 - 589 2016.8
-
Duloxetine, a serotonin and norepinephrine reuptake inhibitor, reduces daily OFF time in Parkinson's disease
M. Tomiyama, Y. Funamizu, T. Kon, R. Haga, T. Ueno, H. Nishijima, A. Arai, C. Suzuki, J. I. Nunomura, M. Baba
MOVEMENT DISORDERS 31 S620 - S620 2016.6
-
パーキンソン病におけるオートファジー関連因子に関する研究
冨山 誠彦, 今 智矢, 三木 康生, 松宮 朋穂
青森県立中央病院医誌 61 ( 2 ) 87 - 87 2016.6
-
1
Suzuki C, Kon T
Aomori Kenritsu Tyuuoubyouin Ishi 61 ( 2 ) 86 - 87 2016.6
-
SRP
Nishijima H, Kon T
Aomori Kenritsu Tyuuoubyouin Ishi 61 ( 2 ) 75 - 79 2016.6
-
MSA
Kon T
Rinshoshinkeigaku 55 ( Suppl. ) S276 - S276 2015.12
-
neuromyelitis optica spectrum disorder
Kon T
Rinshoshinkeigaku 55 ( 12 ) 954 - 954 2015.12
-
PSP
Nunomura J, Kon T
Rinshoshinkeigaku 55 ( Suppl. ) S319 - S319 2015.12